Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease

Patients with autoimmune rheumatic diseases (AIRD) are suspected to have less robust immune responses during COVID-19 due to underlying immune dysfunction and the use of immune-suppressive drugs. Fifty consecutive patients with a diagnosis of AIRD on disease-modifying drugs were included at around 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Shenoy, Padmanabha, Ahmed, Sakir, Shanoj, K. C., Shenoy, Veena, Damodaran, Deepak, Menon, Aparna R., Alias, Bazil, SanjoSaijan, Devakumar, Divya, Babu, A. S. Sageer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216872/
https://www.ncbi.nlm.nih.gov/pubmed/34155573
http://dx.doi.org/10.1007/s10067-021-05801-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216872/
https://www.ncbi.nlm.nih.gov/pubmed/34155573
http://dx.doi.org/10.1007/s10067-021-05801-9

Ejemplares similares